drug
doravirine
Marketedupdated 3mo agoby Merck Sharp & Dohme Corp (Inactive)
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugDELSTRIGO39 co-mentions · 14 sources
- tagApproval38 co-mentions · 13 sources
- drugPIFELTRO32 co-mentions · 14 sources
- tagSmall Molecule19 co-mentions · 13 sources
- drug(doravirine + lamivudine + tenofovir disoproxil fumarate)7 co-mentions · 7 sources
- tagInfectious Disease1 co-mentions · 1 sources
- tagPDUFA1 co-mentions · 1 sources
- drug(doravirine + islatravir hydrate)1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 1 investigational indication.
all catalysts(6)
approval · 6
Aug 30, 2018
approval
$MRK130.42-0.38%
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Sep 19, 2019
approval
$MRK130.42-0.38%
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Oct 10, 2019
approval
$MRK130.42-0.38%
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Jan 27, 2022
approval
$MRK130.42-0.38%
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Nov 7, 2024
approval
$MRK130.42-0.38%
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Oct 29, 2025
approval
$MRK130.42-0.38%
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Trials studying doravirine
- phase1Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant Women
- phase4Study on PhArmacokinetics of First liNe Antiretrovirals in Healthy Breastfeeding Volunteers
- phase2Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
- EP1Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
- phase4Efficacy and Safety of Doravirine in the Rapid Initiation
- phase3DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection
- —Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
- phase2DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 30, 2032
~6.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Aug 30, 2032compositionUS 8486975
News(1)
- Merck adds to pharma’s AI push; Roche details MS drug resultsMerck is making a $1 billion investment in a deal with Google Cloud. Elsewhere, Roche pitched its case for a closely watched multiple sclerosis pill and Arcus and Gilead are ending a yearslong alli…biopharma_dive · 3mo ago
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that